Lurasidone-induced anemia: Is there a need for hematological monitoring?

Lurasidone is a newer drug used for treating schizophrenia and depression in bipolar disorder. Although comparatively safe, some side effects can occur with its use such as akathisia, extrapyramidal reaction, metabolic syndrome, and hyperprolactinemia. Blood dyscrasia with lurasidone is rarely repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirpekar, Vivek C., Faye, Abhijeet D., Bhave, Sudhir H., Tadke, Rahul, Gawande, Sushil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759524/
https://www.ncbi.nlm.nih.gov/pubmed/31571715
http://dx.doi.org/10.4103/ijp.IJP_434_18
_version_ 1783453707833180160
author Kirpekar, Vivek C.
Faye, Abhijeet D.
Bhave, Sudhir H.
Tadke, Rahul
Gawande, Sushil
author_facet Kirpekar, Vivek C.
Faye, Abhijeet D.
Bhave, Sudhir H.
Tadke, Rahul
Gawande, Sushil
author_sort Kirpekar, Vivek C.
collection PubMed
description Lurasidone is a newer drug used for treating schizophrenia and depression in bipolar disorder. Although comparatively safe, some side effects can occur with its use such as akathisia, extrapyramidal reaction, metabolic syndrome, and hyperprolactinemia. Blood dyscrasia with lurasidone is rarely reported in the literature except for few case reports. We present two cases of schizophrenia, treated with lurasidone developing anemia after variable period of treatment and reverting after stopping lurasidone. These cases emphasize the timely monitoring of blood parameters for prevention or early detection of anemia in patients treated with lurasidone.
format Online
Article
Text
id pubmed-6759524
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67595242019-09-30 Lurasidone-induced anemia: Is there a need for hematological monitoring? Kirpekar, Vivek C. Faye, Abhijeet D. Bhave, Sudhir H. Tadke, Rahul Gawande, Sushil Indian J Pharmacol Short Communication Lurasidone is a newer drug used for treating schizophrenia and depression in bipolar disorder. Although comparatively safe, some side effects can occur with its use such as akathisia, extrapyramidal reaction, metabolic syndrome, and hyperprolactinemia. Blood dyscrasia with lurasidone is rarely reported in the literature except for few case reports. We present two cases of schizophrenia, treated with lurasidone developing anemia after variable period of treatment and reverting after stopping lurasidone. These cases emphasize the timely monitoring of blood parameters for prevention or early detection of anemia in patients treated with lurasidone. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6759524/ /pubmed/31571715 http://dx.doi.org/10.4103/ijp.IJP_434_18 Text en Copyright: © 2019 Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Short Communication
Kirpekar, Vivek C.
Faye, Abhijeet D.
Bhave, Sudhir H.
Tadke, Rahul
Gawande, Sushil
Lurasidone-induced anemia: Is there a need for hematological monitoring?
title Lurasidone-induced anemia: Is there a need for hematological monitoring?
title_full Lurasidone-induced anemia: Is there a need for hematological monitoring?
title_fullStr Lurasidone-induced anemia: Is there a need for hematological monitoring?
title_full_unstemmed Lurasidone-induced anemia: Is there a need for hematological monitoring?
title_short Lurasidone-induced anemia: Is there a need for hematological monitoring?
title_sort lurasidone-induced anemia: is there a need for hematological monitoring?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759524/
https://www.ncbi.nlm.nih.gov/pubmed/31571715
http://dx.doi.org/10.4103/ijp.IJP_434_18
work_keys_str_mv AT kirpekarvivekc lurasidoneinducedanemiaisthereaneedforhematologicalmonitoring
AT fayeabhijeetd lurasidoneinducedanemiaisthereaneedforhematologicalmonitoring
AT bhavesudhirh lurasidoneinducedanemiaisthereaneedforhematologicalmonitoring
AT tadkerahul lurasidoneinducedanemiaisthereaneedforhematologicalmonitoring
AT gawandesushil lurasidoneinducedanemiaisthereaneedforhematologicalmonitoring

Ejemplares similares